(RTTNews) - Alpha Tau Medical Ltd. (DRTS) has achieved a historic milestone, announcing the successful treatment of the first patient in the U.S. pilot trial for recurrent glioblastoma using its novel ...
The first use of Alpha DaRT in a human brain tumor sets a new clinical precedent and may signal a company on the verge of broader recognition. Alpha Tau Medical (NASDAQ: DRTS), a company still flying ...
Forbes contributors publish independent expert analyses and insights. Dr. Tracy Brower writes about joy, community and the future of work. Gen Alpha is growing up fast and it’s time to focus on who ...
Crescent Energy is well-positioned after strategic asset divestitures and acquisitions across the Permian, Eagle Ford, and Uinta basins. CRGY improved EBITDA margins and reduced production breakevens, ...
Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...